A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Alzheimer's Disease

In brief

A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week double-blind treatment period.

Key facts

Study ID
NCT00672945
Run by
Epix Pharmaceuticals, Inc.
People needed
420
Starts
2008-04-01
Last updated by the study team
2009-07-30

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.